Oct. 24 at 3:27 PM
$PM $TLRY $ELTP
Meetings with each other???????? Group of GOATS talking,
Philip Morris has focused its cannabis strategy on the medical and wellness sectors, distinguishing its approach from competitors that have pursued recreational markets.
Acquisition of Syqe Medical: In 2023, PMI completed the acquisition of Israeli company Syqe Medical. Syqe is known for its metered-dose cannabis inhaler, and the acquisition was contingent on the device receiving FDA approval in the U.S..
Pharmaceutical and wellness subsidiary: PMI is expanding its footprint in the wellness space through its subsidiary, Vectura Fertin Pharma. This arm of the company partners with firms specializing in cannabinoid-based products.
Focus on regulation: This measured approach, which emphasizes regulatory compliance and medical applications, sets PMI apart from other tobacco companies that have made larger, more public bets on the recreational market.